Patent Case Law 2024 – London

Audience

All

Programme & Speakers

Tuesday 10th December

• 12:30 - 13:30 - Registration & Networking Lunch
• 13:30 - 13:40 - Introduction by Chair
• 13:40 - 14:25 - IPO Patent Case Law Updates

  Speakers

  

  Ben Micklewright, IPO

  Ben Micklewright, IPO

  Ben Micklewright is a Deputy Director in the Intellectual Property Office’s Policy and Legal Division. He has particular responsibility for domestic legislation and practice for patents, trade marks and registered designs. He also leads on legal work in the IPO’s Transformation programme which is aimed at transforming the IPO’s services. Ben’s career at the IPO has spanned over 20 years, joining initially as a patent examiner working in computing technologies following a PhD in physics. He has had a varied career, working in the IPO’s policy and legal teams and leading a number of patent examination teams, including the team responsible for examining patent applications in the computing field. For some years he was in charge of the recruitment of new patent examiners. Ben is also a patents hearing officer, hearing cases on a variety of legal and substantive matters.

• 14:25 - 15:10 - UK Patent Case Law Updates

  Speakers

  

  Jon Markham, Beck Greener

  Jon Markham, Beck Greener

  Jonathan is a partner at Beck Greener in London. He joined Beck Greener in 2009, having previously worked in-house for Dyson. His background is in physics, with a PhD in organic LED displays. Jonathan is a contributing author to the CIPA Black Book, the standard reference text for patent attorneys. He is a regular speaker and presenter.

• 15:10 - 15:30 - Refreshment Break
• 15:30 - 16:15 - EPO Patent Case Law Updates

  Speakers

  

  Maeve O’Flynn, Finnegan Europe LLP

  Maeve O’Flynn, Finnegan Europe LLP

  Maeve O’Flynn is a partner in Finnegan Europe’s London office. She is a European and UK patent attorney with more than a decade of in-house experience, having worked at some of the world’s largest multinational corporations in the oil and chemical industries. Maeve has worked for a range of clients, from startups to multinationals, covering diverse technologies such as cosmetics, sustainable chemistry, and catalysis. She has helped clients develop commercially relevant intellectual property strategies. This includes developing and managing global patent portfolios, provisioning advice regarding trade secrets and defensive publications, and negotiating collaboration and licensing agreements.

• 16:15 - 17:00 - US Patent Case Law Updates

  Speakers

  

  Yelena Morozova, Finnegan LLP

  Yelena Morozova, Finnegan LLP

  Yelena is an experienced patent attorney with technical expertise across different fields of engineering, most particularly in information technology and software, telecommunications, and AI. Being qualified in the US and in Europe, Yelena practices in both jurisdictions, focusing on patent procurement and portfolio development for a diverse range of global clients. Using her knowledge of the different legal approaches employed on both sides of the Atlantic, Yelena provides a pragmatic advice and develops creative solutions enabling businesses to meet their commercial objectives.

  Yelena currently serves on the Board of Directors of the American Intellectual Property Law Association (AIPLA) and is the Board liaison to the AIPLA international committees. She also is an active member of the Women in IP Group of the IP Inclusive Task Force.

  

  Amanda K. Murphy, Finnegan

  Amanda K. Murphy, Finnegan

  Amanda Murphy, Ph.D., brings over 17 years of experience to her life sciences intellectual property practice. As a U.S. patent attorney practicing in London, Amanda is ideally situated to counsel clients on their global patent strategies. Her practice includes patent application preparation and prosecution, pre-litigation portfolio and due diligence analyses, and contentious PTAB proceedings.

  Amanda focuses on developing patent filing and prosecution strategies tailored to clients’ worldwide business goals. She works with a wide range of clients, including small biotech startup companies, research foundations, and large publicly traded biotechnology and pharmaceutical companies.

• 17:00 - 17:10 - Closing Remarks
• 17:10 - 19:00 - Drinks Reception